Home » Health » the new Sputnik V vaccines last three days and the mystery continues with Sinopharm and Covishield

the new Sputnik V vaccines last three days and the mystery continues with Sinopharm and Covishield

The mystery about the amount of Sputnik V vaccines that finally arrive in Argentina this Friday finished when the government announced that they are 330 thousand doses those that will arrive. Is a drink of water in the desert: according to the vaccination figures, they will reach the country for just over three days.

President Alberto Fernández celebrated on the national network this Thursday night that the country in the last week had been able to apply an average of 100,000 vaccinations daily. This “acceleration” is what at the same time reveals the impossibility of continuing with this rhythm with the available dose flow.

In recent days, both the City of Buenos Aires and the Province warned about the vaccine shortage. In the first case, they said that the stock was enough until this weekend. In the second, for one more week. In Córdoba, for example, today they already announced that there were no vaccines to apply.

But the new batch of Sputnik will be hardly a respite if it does not quickly leave for Russia, as it is already being transcended, another flight that restocks the stock. In the specific case of the City, the amount that it would have would be 23,400 doses: that if its vaccination rate is taken into account, it would be enough for two days approximately.

Meanwhile, there are other unknowns. One is when the three million vacunas Sinopharm announced last week. On that point the Government did not give any new details. And under the new official policy, hopefully he won’t give them until the vaccines are loaded onto the plane.

There are 330,000 more doses that are added to the 4 million vaccines that in total had reached Argentina.


In this case, these are vaccines that can only be applied to under 60 years, until the documentation with the phase 3 trials does not arrive in the country and the ANMAT can study them to eventually recommend to the Government to start applying it to that risk group.

The other mystery is the second batch of Covishield. The first, of 580 thousand doses, arrived at the end of February and it was announced that the second would arrive before the end of March. Clarion He consulted the AstraZeneca laboratory (Covishield is the same vaccine but produced in India) and so far they could not give details on when that remnant will arrive.

Finally, it is expected that the AstraZeneca vaccines that are manufactured in Argentina may be available for the second week of april. There our country has deposited 22.4 million hopes. That is, the doses that you bought and that would be a great relief if they arrive in a timely manner.

But a problem with packaging and administrative issues in Mexico made production is delayed. For this reason, half of the doses produced in Garín’s MabXience laboratory had to be transferred to another plant in the United States. In this way, the laboratory I would manage to overcome that obstacle and meet the deadlines.

Between so much uncertainty and scarcity, This Friday the good news was known that India will finally produce Sputnik V. One of the reasons for the bottleneck with Russian doses had to do, precisely, with the fact that the world’s largest vaccine manufacturer production had not yet started.

Now it was announced that India will produce 200 million doses of Sputnik V. It is a hope for Argentina, which bought 20 million doses from the Gamaleya laboratory and until now has been able to receive little more than 10 percent, practically “courtesy” lots given by Moscow to our country.

The lack of vaccines coincides with the arrival of the cold and the second wave of coronavirus just around the corner. It is in this scenario that yesterday the President admitted that the vaccination plan it’s not going as expected in Argentina. And he claimed to maintain the care “so that the Covid does not isolate us again.”

PS

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.